Rangeley Capital’s scPharmaceuticals SCPH Stock Holding History

Rangeley Capital’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-93,747	Closed	-$532K	–	154
2025 Q3	$532K	Buy	+93,747	New	+$480K	0.46%	50

Rangeley Capital's SCPH Position: Q4 2025 in Review

Rangeley Capital sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 93,747 shares — an estimated $532K sold.

Rangeley Capital first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $532K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Rangeley Capital reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Rangeley Capital sold 93,747 scPharmaceuticals shares in Q4 2025, an estimated $532K.
Rangeley Capital first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
Rangeley Capital's scPharmaceuticals position peaked at $532K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Rangeley Capital's 13F filing for Q4 2025, filed 17 Feb 2026.